Cellular Imaging
How do you know if your patient’s next gen cancer therapy is working?
MPI can tell you.
We see more.
Our Magnetic Particle Imaging (MPI) technology can rapidly assess if a patient’s immunotherapy regimen is working.
Getting patients to the right therapy is key.
Rapid feedback lets you know if a patient is on the right track to a cancer-free future.
Magnetic Insight is revolutionizing cellular imaging of T-cells.
MPI offers unprecedented insights and we have decades of experience in the field.
Cellular imaging using MPI enables detecting, tracking, and quantifying T cells and NK cells in vivo. Over time, it allows for studying cellular events in disease processes and may be used as a biomarker to help make treatment decisions and monitor treatment response.
The need for cellular imaging is rapidly expanding within modern medicine, with numerous applications in immunotherapy monitoring and regenerative medicine.
Read the publications of our partners to learn more about cellular imaging using MPI:
- Zheng et al. Quantitative magnetic particle imaging monitors the transplantation, biodistribution, and clearance of stem cells in vivo. 2016; 6(3): 291-301.
- Wang et al. Magnetic particle imaging of islet transplantation in the liver and under the kidney capsule in mouse models. Quant Imaging Med Surg. 2018;8(2): 114-122.
- Rivera-Rodriguez, Angelie, et al. "Tracking adoptive T cell immunotherapy using magnetic particle imaging." Nanotheranostics 5.4 (2021): 431.
- Wu, Wei Emma, et al. "Multimodal In Vivo Tracking of Chimeric Antigen Receptor T Cells in Preclinical Glioblastoma Models." Investigative Radiology 58.6 (2023): 388-395.
- Kiru, Louise, et al. "In vivo imaging of nanoparticle-labeled CAR T cells." Proceedings of the National Academy of Sciences 119.6 (2022): e2102363119.
- Fink, Corby, et al. "In vivo tracking of adenoviral-transduced iron oxide-labeled bone marrow-derived dendritic cells using magnetic particle imaging." European Radiology Experimental 7:42 (2023).
